% | $
Quotes you view appear here for quick access.

Neurocrine Biosciences Inc. Message Board

  • frogsleapmerlot frogsleapmerlot Nov 24, 2003 10:41 AM Flag

    IBD Monday 11/24 Insomnia Artical

    Page 9, Is The Drug Industry Asleep At The Wheel Regarding Insomnia? Indiplon will be the clear winner partly due to a better product marketing label and Pfizer as a power house marketing partner. Indiplon FY2007 sales projected @ $1.2 BILLION by some analyst and growing. That equates to Huge earnings for NBIX as its a 50/50 partnership in North America.
    SEPR Estorra Sales
    04, $50M
    05, $150M
    06, $300M
    07, $400m
    NBIX Indiplon
    05, $250M
    06, $647M
    07, $1.2Billion

    SortNewest  |  Oldest  |  Most Replied Expand all replies
45.65-0.02(-0.04%)Oct 21 4:00 PMEDT